Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

TLR3 unveiled as therapeutic target for treating pulmonary hypertension

Jan. 31, 2019

Coagulation factor XI inhibitors identified at Sichuan Kelun-Biotech Biopharmaceutical

Jan. 30, 2019

Relaxation Rx for hypertrophic cardiomyopathy

Jan. 29, 2019

Withyou Biotechnology describes new ACE inhibitors

Jan. 28, 2019

New phase I trial investigates use of MK-5475 in moderate to severe PAH

Jan. 28, 2019

Collateral undamage: novel arterial growth mechanism underlies neonatal heart regeneration

Jan. 28, 2019

HIF-2alpha inhibitor reverses pulmonary vascular remodeling, inhibits RHF, promotes survival in PAH

Jan. 24, 2019

FDA issues complete response letter for Opsumit sNDA for CTEPH

Jan. 17, 2019

Theravance opens phase III study of TD-9855 to treat symptomatic neurogenic orthostatic hypotension

Jan. 11, 2019

Minnebro approved in Japan for hypertension

Jan. 8, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...